- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A study to investigate safety, tolerability, pharmacokinetics and efficacy of REM0045392 compared with placebo in healthy participants
This study is looking at a new medicine called REM0045392 for Alzheimer's disease. Researchers want to see if it's safe to use in healthy people and how the body handles it. This is a very early stage of testing, to understand the medicine better.
Belgium - authorisedPhase II and Phase III (Integrated)
CIRAANO: Multimodal exploration (including radiopharmaceuticals Amyvid® and Tauvid®) of theater actors, memory athletes, and patients with various memory pathologies: evaluation of mnesic strategies and their cerebral substrates, and contribution to the treatment of memory pathologies.
This study looks at memory in different groups, including actors, memory athletes, and people with memory problems like Alzheimer's. It uses special brain scans to understand how different memory strategies work in the brain and how this might help treat memory conditions.
France